Pantoprazole Gastro Resistant and Domperidone Prolonged Release Capsules IP – Zulbex DSR Capsules

Pantoprazole Gastro Resistant and Domperidone Prolonged Release Capsules IP – Dual-Action Relief for Acid Reflux & Motility Disorders

Zulbex DSR Capsules – Pantoprazole- 40mg + Domperidone -30mg Sustained Release capsules dual-release formulation is designed for enhanced acid suppression and gastric motility improvement:
Pantoprazole is proton pump inhibitor (PPI) that inhibits the H+/K+ ATPase pump, effectively reducing stomach acid production.
Domperidone is a dopamine D2 receptor antagonist that promotes gastric emptying and prevents nausea & bloating by blocking dopamine receptors in the gut.

Recommended By Specialists
Gastroenterologists: It is preferred to treat the disease associated with acid reflux, dyspepsia, functional dyspepsia, or delayed gastric emptying
General Physician: It should be preferred to treat the disease associated with mild-to-moderate gastritis, gastric discomfort, and acidity with bloating

Key Benefits of Pantoprazole Gastro Resistant and Domperidone Prolonged Release Capsules IP – Zulbex DSR Capsules
Instant & Sustained Acid Control – Pantoprazole provides prolonged acid suppression, while Domperidone IR ensures rapid symptom relief, making it ideal for GERD, dyspepsia, and acid reflux.
Optimized Prokinetic Support – The Domperidone dual-release formulation offers immediate gastric emptying support and sustained prokinetic action, reducing bloating, nausea, and regurgitation.
Superior to PPI Monotherapy – The combination effectively prevents acid reflux and motility dysfunction, ensuring faster and longer-lasting symptom relief compared to PPIs alone.

INDICATIONS:
Gastroesophageal Reflux Disease (GERD)
Functional Dyspepsia
Chronic Acid Reflux
Post-Meal Bloating & Nausea
Delayed Gastric Emptying